USP 231 heavy metals (重金属)
(完整版)USP231重金属

USP<231>重金属本检验用以证实供试品中与硫离子作用显色的金属杂质含量,在规定检验条件下,不超过个论中规定的供试品重金属限度,以铅百分含量(重量比)计,与用标准铅溶液配制的对照进行目测比较(参看分光光度法和光散射法<851>中操作步骤部分的视觉比较)测定。
[注意:与本检验起反应的代表性物质为铅、汞、铋、砷、锑、锡、镉、银、铜和钼。
]除个论另有规定外,用方法I测定重金属含量。
方法I用于规定条件下可生成无色的、透明的制品的物质。
方法II适用于在方法I规定条件下无法生成无色透明制品的物质,或由于自身复杂特性,会对硫离子生成的金属沉淀造成干扰的物质,以及不挥发油和挥发油。
方法III湿消化法,仅在方法I和方法II均不适用时使用。
专用试剂硝酸铅贮备液:取硝酸铅159.8 mg,加已加硝酸1 mL的水100 mL,溶解,加水稀释至1000 mL。
于不含可溶铅盐的玻璃容器中配制和贮存该溶液。
标准铅溶液:使用当天配制。
取硝酸铅贮备液10.0 mL,加水稀释至100.0 mL。
每mL标准铅溶液相当于10 µg的铅。
以每g供试品100µL标准铅溶液为基准制备的参比溶液相当于每一百万份供试品中含有一份铅。
方法IpH 3.5醋酸盐缓冲液:取醋酸铵25.0 g,加水25 mL,溶解,加6 mol/L盐酸38.0 mL。
如有需要,用6 mol/L氨水或6 mol/L盐酸调节pH 为3.5,用水稀释至100 mL。
混匀。
标准溶液:用移液管取标准铅溶液2 mL(20 µg的铅),置50 mL比色管中,用水稀释至25 mL。
使用pH计或窄范围pH试纸作外部指示剂,用1mol/L醋酸或6mol/L氨水调节pH至3.0-4.0,用水稀释至40 mL,混匀。
供试溶液:取如个论所述制备的供试液25 mL,置50 mL比色管中;或当个论另有规定时,使用个论中规定体积量的酸溶解,并用水稀释至25 mL。
USP 231中文

USP<231 >重金属-方法1+2此次试验是提供阐明被硫化物染色的重金属物质含量,在特定情况下,在测试物质中铅含量(重量)不超过标准规定的限值。
其方法为通过与标准配制的标准铅溶液目视比色。
注1:在此次试验具有明显回应(显色)的物质为铅,汞,砷,锡,锑,镉,银,铜与钼。
注2:在可见光与紫外光目视比色的方法见<851>除非另有个别标准文献中规定,一般采用方法1测定重金属含量。
方法1用于在特定测试条件下产生透明,无色的指示剂的物质。
方法2用于在方法1规定的试验条件下不产生透明,无色的指示剂的物质,或者由于其复合性质,通过硫化物离子或固定和挥发性物质干扰金属沉淀的物质油。
方法3是一个湿度消化的方法,仅在方法1与方法2都不适用的情况下使用。
1 特定试剂制备1.1硝酸铅储备液的配制159.8mg硝酸铅溶于含有1ml硝酸的100ml纯化水中,然后稀释到1000ml,稀释液为纯化水。
配制与存放使用玻璃容器,远离可溶性铅盐。
1.2铅标准溶液现用现配,稀释10ml硝酸铅储备液加水至100ml。
铅标准溶液浓度为10ug/ml.方法12-方法1所需试剂2.1 Ph3.5乙酸盐缓冲液25.0g的乙酸铵溶于25ml水中,加入38ml6mol/L的盐酸。
若有需要则使用6mol/L氨水或者6mol/L的盐酸调节ph至3.5.加水稀释至100ml.2.2配制标准液在50ml比色管中加入2ml铅标准溶液(10ug/ml)加水稀释至25ml.使用ph 计或者ph试纸作为外部检测指示器,用1mol/L的醋酸或者6mol/L氨水调节ph至3.0-4.0,然后加水稀释至40ml,混匀。
2.3试验液配制在50ml比色管中加入25ml测试液,(或使用指定体积的酸,在个别专着中规定的情况下,溶解并用水稀释至25 mL,待测物质的量(g),按公式2.0 /(1000L)计算,其中L为重金属限值,%。
)使用ph计或者ph试纸作为外部检测指示器,用1mol/L的醋酸或者6mol/L氨水调节ph至3.0-4.0,然后加水稀释至40ml,混匀。
USP232-233重金属检测方法-中文

铑
10
40
0.0001
钌
10
40
0.0002
铬
25
100
0.002
钼
25
100
0.0002
镍
25
100
0.002
钒
25
100
0.005
铜
250
1000
0.002
镁
250
1000
0.001
样品制备
范围广泛的各种样品都可以用 USP<232>/<233> 进行分 析,所以提供适合所有样品类型的详细样品处理方法并不现 实。有些药物样品可以直接分析(不用溶解),而其他样品 可以用水性溶剂(如水或稀酸)或适当的有机溶剂(如 2-丁 氧乙醇 : 水(25 : 75)[3],DMSO 或 DGME)简单稀释或 溶解进行制备。用水性或有机溶剂进行简单稀释或溶解的 方法必须考虑样品的化学稳定性,并且对于有机溶剂溶解, 还要考虑样品中组分化合物的不同挥发性。对许多 API 来 说,用有机溶剂稀释是首选方法,这种情况下有必要采取有 助于稳定分析物的方法,以避免因较高或较低挥发性(与校 正标准品相比)成分的存在而造成的回收率波动 [7]。
元素 镉 铅 无机砷 无机汞 铱 锇 钯 铂 铑 钌 铬 钼 镍 钒 铜 镁
每日剂量 PDE(µg/日) 5 10 15 15 100 100 100 100 100 100 250 250 250 250 2500 2500
虽然 USP<232> 中制定的 PDE 限度用任何 USP<233> (ICP-OES 或 ICP-MS)中参考的仪器技术都可以测定 [6], 但许多新药中使用越来越复杂而珍贵的原料药,可能只包 含非常少的量。对这些毫克级样品进行大比例稀释制备, 意味着使用检测限尽可能低的仪器非常重要。低检测限和 宽动态范围线性校正(安捷伦 7700 系列达到 9 个数量级) 是 ICP-MS 最非常可贵的特性。低检测限对于 USP<232> 要求必须以最低限量进行控制的潜在毒性痕量元素(特别是 As、Cd、Hg 和 Pb)尤为重要。
USP35(231)重金属检查第二法中英对照

Method II方法ⅡpH 3.5 Acetate Buffer— Prepare as directed under Method I.取醋酸铵25.0g,加水25ml溶解后,加38.0ml6N盐酸,如有必要用6N氨水或6N 盐酸调PH至3.5 ,用水稀释至100ml,摇匀。
Standard Preparation— Prepare as directed under Method I.标准溶液的制备取50ml比色管,用移液管移取2.0ml标准铅溶液(20 gPb),用水稀释到25ml,用1N醋酸或6N氨水溶液调PH至3.0~4.0之间,用窄范围的精密pH试纸作指示,然后加水稀释至40ml,摇匀。
Test Preparation— Use a quantity, in g, of the substance to be tested as calculated by the formula:2.0 / (1000L),供试品溶液的制备称取一定量的样品(以g计算) ,按公式2.0/1000L计算,in which L is the Heavy metals limit, in percentage. Transfer the weighed quantity of the substance to a suitable crucible, add sufficient sulfuric acid to wet the substance, and carefully ignite at a low temperature until thoroughly charred. (The crucible may be loosely covered with a suitable lid during the charring.)其中L为重金属的限度(%),置适宜的坩埚中,加适量的硫酸预以湿润,在低温小心炽灼,直至全部炭化,(炭化过程坩埚盖可不盖严),Add to the carbonized mass 2 mL of nitric acid and 5 drops of sulfuric acid, and heat cautiously until white fumes no longer are evolved. Ignite, preferably in a muffle furnace, at 500 to 600, until the carbon is completely burned off.炭化物中加2ml硝酸和5滴硫酸,小心加热,直至不再挥发白色烟雾,于500~600℃炽灼, 直至炭完全灰化。
USP 231重金属

USP<231>重金属本检验用以证实供试品中与硫离子作用显色的金属杂质含量,在规定检验条件下,不超过个论中规定的供试品重金属限度,以铅百分含量(重量比)计,与用标准铅溶液配制的对照进行目测比较(参看分光光度法和光散射法<851>中操作步骤部分的视觉比较)测定。
[注意:与本检验起反应的代表性物质为铅、汞、铋、砷、锑、锡、镉、银、铜和钼。
]除个论另有规定外,用方法I测定重金属含量。
方法I用于规定条件下可生成无色的、透明的制品的物质。
方法II适用于在方法I规定条件下无法生成无色透明制品的物质,或由于自身复杂特性,会对硫离子生成的金属沉淀造成干扰的物质,以及不挥发油和挥发油。
方法III湿消化法,仅在方法I和方法II均不适用时使用。
专用试剂硝酸铅贮备液:取硝酸铅159.8 mg,加已加硝酸1 mL的水100 mL,溶解,加水稀释至1000 mL。
于不含可溶铅盐的玻璃容器中配制和贮存该溶液。
标准铅溶液:使用当天配制。
取硝酸铅贮备液10.0 mL,加水稀释至100.0 mL。
每mL标准铅溶液相当于10 µg的铅。
以每g供试品100µL标准铅溶液为基准制备的参比溶液相当于每一百万份供试品中含有一份铅。
方法IpH 3.5醋酸盐缓冲液:取醋酸铵25.0 g,加水25 mL,溶解,加6 mol/L盐酸38.0 mL。
如有需要,用6 mol/L氨水或6 mol/L盐酸调节pH 为3.5,用水稀释至100 mL。
混匀。
标准溶液:用移液管取标准铅溶液2 mL(20 µg的铅),置50 mL比色管中,用水稀释至25 mL。
使用pH计或窄范围pH试纸作外部指示剂,用1mol/L醋酸或6mol/L氨水调节pH至3.0-4.0,用水稀释至40 mL,混匀。
供试溶液:取如个论所述制备的供试液25 mL,置50 mL比色管中;或当个论另有规定时,使用个论中规定体积量的酸溶解,并用水稀释至25 mL。
USP美国药典,二甘醇、乙二醇及其他杂质

GlycerinC 3H 8O 3 92.101,2,3-Propanetriol.Glycerol [56-81-5].» Glycerin contains not less than 99.0 percent and not more than 101.0 percent of C 3H 8O 3, calculated on the anhydrous basis. The amount of any individual impurity, excluding diethylene glycol and ethylene glycol, if detected, meets the requirements under Other Impurities (NMT 0.1%) and the amount of total impurities, including diethylene glycol and ethylene glycol, is NMT 1.0%. Packaging and storage— Preserve in tight containers.USP Reference standards 11— USP Diethylene Glycol RS . USP Ethylene Glycol RS . USP Glycerin RS .Color— Its color, when viewed downward against a white surface in a 50-mL color-comparison tube, is not darker than the color of a standard made by diluting 0.40 mL of ferric chloride CS with water to 50 mL and similarly viewed in a color-comparison tube of approximately the same diameter and color as that containing the Glycerin.Identification— [NOTE—Compliance is determined by meeting the requirements for both Identification A and B .]A: Infrared Absorption 197F .B: Standard stock solution 1—Transfer 50 mg of USP Diethylene Glycol RS , accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix. Standard stock solution 2— Transfer 50 mg of USP Ethylene Glycol RS , accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Standard stock solution 3— Transfer 50 mg of USP Glycerin RS , accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Resolution solution— Transfer 5.0 mL each of Standard stock solution 1, Standard stock solution 2, and Standard stock solution 3, to a 100-mL volumetric flask, dilute withmethanol to volume, and mix.Test solution— Transfer about 5 g of Glycerin to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Chromatographic system (see Chromatography 621)— The gas chromatograph is equipped with a flame-ionization detector, a 0.53-mm × 30-m fused-silica analytical column coated with 3.0-µm G43 stationary phase. The injection port temperature is maintained at 220 and the detector temperature is maintained at 250. The carrier gas is helium with a flow rate of about 4.5 mL per minute. The split flow ratio is about 10:1. The chromatograph is programmed as follows: Initially, the column temperature is equilibratedat 100 for 4 minutes, then increased at a rate of 50 per minute to 120, and is maintained at 120 for 10 minutes. It is then increased at a rate of 50 per minute to 220, and is maintained at 220 for 6 minutes. Chromatograph the Resolution solution, and record the peak responses and retention times as directed for Procedure: the relative retention times are about 0.3 for ethylene glycol, 0.8 for diethylene glycol, and 1.0 for glycerin; and the relative standard deviation for replicate injections for the diethylene glycol is not more than 10%.Procedure— Separately inject equal volumes (about 1 µL) of the Resolution solution and the Test solution into the chromatograph, and record the chromatograms. If a peak at the relative retention time for the diethylene glycol or ethylene glycol is present in the Test solution, the peak must be identifed and quantified as directed in the test for Diethylene glycol and ethylene glycol impurities.Specific gravity 841: not less than 1.249.Residue on ignition 281—Heat 50 g in an open, shallow 100-mL porcelain dish until it ignites, and allow it to burn without further application of heat in a place free from drafts. Cool, moisten the residue with 0.5 mL of sulfuric acid, and ignite to constant weight: the weight of the residue does not exceed 5 mg (0.01%).Water, Method I 921: not more than 5.0%.Chloride 221—A 7.0-g portion shows no more chloride than corresponds to 0.10 mL of 0.020 N hydrochloric acid (0.001%).Sulfate 221—A 10-g portion shows no more sulfate than corresponds to 0.20 mL of 0.020 N sulfuric acid (about 0.002%).Heavy metals 231—Mix 4.0 g with 2 mL of 0.1 N hydrochloric acid, and dilute with water to 25 mL: the limit is 5 µg per g.Limit of chlorinated compounds— Accurately weigh 5 g of Glycerin into a dry, round-bottom, 100-mL flask, add 15 mL of morpholine, and connect the flask by a ground joint to a reflux condenser. Reflux gently for 3 hours. Rinse the condenser with 10 mL of water,receiving the washing in the flask, and cautiously acidify with nitric acid. Transfer the solution to a suitable comparison tube, add 0.50 mL of silver nitrate TS, dilute with water to 50.0 mL, and mix: the turbidity is not greater than that of a blank to which 0.20 mL of 0.020 N hydrochloric acid has been added, the refluxing being omitted (0.003% of Cl).Fatty acids and esters— Mix 50 g of Glycerin with 50 mL of freshly boiled water and 5 mL of 0.5 N sodium hydroxide VS, boil the mixture for 5 minutes, cool, add phenolphthalein TS, and titrate the excess alkali with 0.5 N hydrochloric acid VS. Performa blank determination (see Residual Titrations under Titrimetry 541): not more than 1 mL of 0.5 N sodium hydroxide is consumed.Diethylene glycol and ethylene glycol impurities—Internal standard solution— Transfer 100 mg of 2,2,2-trichloroethanol (internal standard), accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Standard stock solution 1— Transfer 50 mg of USP Diethylene Glycol RS, accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Standard stock solution 2— Transfer 50 mg of USP Ethylene Glycol RS, accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Standard stock solution 3— Transfer 50 mg of USP Glycerin RS, accurately weighed, to a 100-mL volumetric flask, dilute with methanol to volume, and mix.Standard solution— Transfer 5.0 mL each of Standard stock solution 1, Standard stock solution 2, and the Internal standard solution to a 100-mL volumetric flask, and dilute with methanol to volume, and mix.Resolution solution— Transfer 500 mg of USP Glycerin RS to a 10-mL volumetric flask, add 0.5 mL each of Standard stock solution 1 and Standard stock solution 2, dilute with methanol to volume, and mix.Test solution— Transfer about 5 g of Glycerin to a 100-mL volumetric flask, add 5.0 mL of Internal standard solution, dilute with methanol to volume, and mix.Chromatographic system (see Chromatography 621)— The gas chromatograph is equipped with a flame-ionization detector, a 0.53-mm × 30-m fused-silica analytical column coated with 3.0-µm G43 stationary phase. The injection port temperature is maintained at 220 and the detector temperature is maintained at 250. The carrier gas is helium, flowing at a rate of about 4.5 mL per minute. The split flow ratio is about 10:1. The chromatograph is programmed as follows. Initially, the column temperature is equilibratedat 100 for 4 minutes, then increased at a rate of 50 per minute to 120, and is maintained at 120 for 10 minutes then increased at a rate of 50 per minute to 220, andis maintained at 220for 6 minutes. Chromatograph the Standard solution, and record thepeak response ratio and retention times as directed for Procedure: the relative retention times are about 0.3 for ethylene glycol, 0.8 for diethylene glycol, and 1.0 for glycerin; the relative standard deviation for replicate injections for the diethylene glycol is not more than 10%; and the limit of quantitation of diethylene glycol and ethylene glycol is not more than 0.025%.Procedure— Separately inject equal volumes (about 1 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the ethylene glycol and diethylene glycol peaks. Calculate the percentage of diethylene glycol and ethylene glycol in the portion of Glycerin taken by the formula:100(CS / CU)(RU/ RS)in which CSis the concentration, in mg per mL, of diethylene glycol (or ethylene glycol) inthe Standard solution; CUis the concentration, in mg per mL, of Glycerin in the Testsolution; and RU and RSare the peak response ratios for diethylene glycol (or ethyleneglycol) to the internal standard peak obtained from the Test solution and the Standard solution: NMT the limit of quantitation for each, is found (0.025%).Assay—Sodium periodate solution— Dissolve 60 g of sodium metaperiodate in sufficient water containing 120 mL of 0.1 N sulfuric acid to make 1000 mL. Do not heat to dissolve the periodate. If the solution is not clear, pass through a sintered-glass filter. Store the solution in a glass-stoppered, light-resistant container. Test the suitability of this solution as follows. Pipet 10 mL into a 250-mL volumetric flask, dilute with water to volume, and mix. To about 550 mg of Glycerin dissolved in 50 mL of water add 50 mL of the diluted periodate solution with a pipet. For a blank, pipet 50 mL of the solution into a flask containing 50 mL of water. Allow the solutions to stand for 30 minutes, then to each add 5 mL of hydrochloric acid and 10 mL of potassium iodide TS, and rotate to mix. Allow to stand for 5 minutes, add 100 mL of water, and titrate with 0.1 N sodium thiosulfate, shaking continuously and adding 3 mL of starch TS as the endpoint is approached. The ratio of the volume of 0.1 N sodium thiosulfate required for the glycerin–periodate mixture to that required for the blank should be between 0.750 and 0.765.Procedure— Transfer about 400 mg of Glycerin, accurately weighed, to a 600-mL beaker, dilute with 50 mL of water, add bromothymol blue TS, and acidify with 0.2 N sulfuric acid to a definite green or greenish yellow color. Neutralize with 0.05 N sodium hydroxide to a definite blue endpoint, free from green color. Prepare a blank containing 50 mL of water, and neutralize in the same manner. Pipet 50 mL of the Sodium periodate solution into each beaker, mix by swirling gently, cover with a watch glass, and allow to stand for 30minutes at room temperature (not exceeding 35) in the dark or in subdued light. Add 10 mL of a mixture of equal volumes of ethylene glycol and water, and allow to stand for 20 minutes. Dilute each solution with water to about 300 mL, and titrate with 0.1 N sodiumhydroxide VS to a pH of 8.1 ± 0.1 for the specimen under assay and 6.5 ± 0.1 for the blank, using a pH meter. Each mL of 0.1 N sodium hydroxide, after correction for the blank, is equivalent to 9.210 mg of C 3H 8O 3.Auxiliary Information— Please check for your question in the FAQs before contacting USP.USP32–NF27 Page 2513Pharmacopeial Forum : Volume No. 28(4) Page 1245Chromatographic Column— GLYCERINChromatographic columns text is not derived from, and not part of, USP 32 or NF 27. Topic/Question Contact Expert Committee Monograph Kevin T. Moore, Ph.D.Scientist1-301-816-8369(EM105) Excipient Monographs 1Reference StandardsLili Wang, Technical ServicesScientist1-301-816-8129RSTech@。
USP38 通用章节目录中文
USP38-通用章节指导目录(附录)Guide to General Chapters 通用章节指导General Requirements for Test and Assays检查与含量分析的一般要求<1>INJECTIONS AND IMPLANTED DRUG PRODUCTS (PARENTERALS)—PRODUCT QUALITY TESTS 注射和植入药物产品(注射用) —产品质量测试<1>INJECTIONS注射剂<2>ORAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 口服药物产品质量测试<3>TOPICAL AND TRANSDERMAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 局部和透皮药物产品—产品质量测试<4>MUCOSAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 粘膜药物产品质量测试<5>INHALATION AND NASAL DRUG PRODUCTS—GENERAL INFORMATION AND PRODUCT QUALITY TESTS 吸入剂产品—产品质量测试<7>LABELING 标签<11>USP REFERENCE STANDARDS USP标准品Apparatus for Test and Assays用于检查与含量分析的器具<17>PRESCRIPTION CONTAINER LABELING处方容器标签<21>THERMOMETERS温度计<31>VOLUMETRIC APPARATUS容量器具<41>BALANCES天平Microbiological Tests 微生物检查法<51>ANTIMICROBIAL EFFECTIVENESS TESTING抗菌剂有效性检查法<55>BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS生物指示剂-耐药性实验<61>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS非无菌产品的微生物限度检查:微生物列举检查法<62>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS 非无菌产品的微生物限度检查:特定微生物检查法<63>MYCOPLASMA TESTS 支原体检查法<71>STERILITY TESTS无菌检查法Biological tests and assays生物检查法与测定法<81>ANTIBIOTICS—MICROBIAL ASSAYS抗生素-微生物测定<85>BACTERIAL ENDOTOXINS TEST细菌内毒素检查法<87>BIOLOGICAL REACTIVITY TESTS, IN VITRO体外的生物反应性检查法<88>BIOLOGICAL REACTIVITY TESTS, IN VIVO 体内的生物反应性检查法<89>ENZYMES USED AS ANCILLARY MATERIALS IN PHARMACEUTICAL MANUFACTURING 药品生产中酶作为辅料所使用<90>FETAL BOVINE SERUM—QUALITY ATTRIBUTES AND FUNCTIONALITY TESTS 牛胎儿血清-质量品质和功能检查法<91>CALCIUM PANTOTHENATE ASSAY泛酸钙测定法<92>GROWTH FACTORS AND CYTOKINES USED IN CELL THERAPY MANUFACTURING 在细胞疗法中使用生长因子和细胞因子<111>DESIGN AND ANALYSIS OF BIOLOGICAL ASSAYS 生物测定法的设计与分析<115>DEXPANTHENOL ASSAY右泛醇(拟胆碱药)测定法<121>INSULIN ASSAYS胰岛素测定法<121.1>PHYSICOCHEMICAL ANALYTICAL PROCEDURES FOR INSULINS胰岛素的物理化学分析程序<123>GLUCAGON BIOIDENTITY TESTS 高血糖素的生物鉴别检查法<124>ERYTHROPOIETIN BIOASSAYS 红细胞生成素的微生物测定<126>SOMATROPIN BIOIDENTITY TESTS 生长激素的生物鉴别检查法<130>PROTEIN A QUALITY ATTRIBUTES 蛋白质A的质量特征<151>PYROGEN TEST热原检查法<161>TRANSFUSION AND INFUSION ASSEMBLIES AND SIMILAR MEDICAL DEVICES 输血输液用具以及相类似的医疗器械<171>VITAMIN B12 ACTIVITY ASSAY……2548维生素B12活性测定法Chemical Tests and assays化学实验检查与测定法鉴别检查<181>IDENTIFICATION—ORGANIC NITROGENOUS BASES鉴别-有机氮碱化合物<191>IDENTIFICATION TESTS—GENERAL鉴别实验-通用<193>IDENTIFICATION—TETRACYCLINES鉴别-四环素类<197>SPECTROPHOTOMETRIC IDENTIFICATION TESTS分光光度计鉴别实验<201>THIN-LAYER CHROMATOGRAPHIC IDENTIFICATION TEST薄层色谱鉴别实验Limit Tests 限度检查法<206>ALUMINUM铝<207>TEST FOR 1,6-ANHYDRO DERIV ATIVE FOR ENOXAPARIN SODIUM依诺肝素钠的酐类衍生物实验<208>ANTI-FACTOR Xa AND ANTI-FACTOR IIa ASSAYS FOR UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS普通肝素和低分子肝素产品中抗体Xa和抗体IIa测定<209>LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS 低分子肝素钠分子量测定<211>ARSENIC砷<221>CHLORIDE AND SULFATE氯和硫<223>DIMETHYLANILINE二甲基苯胺<226>4-EPIANHYDRO-TETRACYCLINE4-?-四环素<227>4-AMINOPHENOL IN ACETAMINOPHEN-CONTAINING DRUG PRODUCTS 对乙酰氨酚药物产品中氨基酚<228>ETHYLENE OXIDE AND DIOXANE 环氧乙烷和二氧六环<231>HEA VY METALS重金属(删除)<232>ELEMENTAL IMPURITIES—LIMITS 元素杂质-限度<233>ELEMENTAL IMPURITIES—PROCEDURES 元素杂质-规程<241>IRON铁<251>LEAD铅<261>MERCURY汞<267>POROSIMETRY BY MERCURY INTRUSION 水银孔隙仪<268>POROSITY BY NITROGEN ADSORPTION–DESORPTION 氮吸附-解吸测定孔隙率<271>READILY CARBONIZABLE SUBSTANCES TEST易碳化物检查法<281>RESIDUE ON IGNITION炽灼残渣<291>SELENIUM硒Other Tests and Assays 其它检查法与测定法<301>ACID-NEUTRALIZING CAPACITY酸中和容量<311>ALGINATES ASSAY藻酸盐测定法<341>ANTIMICROBIAL AGENTS—CONTENT 抗菌剂-含量<345>Assay for Citric Acid/Citrate and Phosphate 柠檬酸/柠檬酸盐和磷酸盐的测定<351>ASSAY FOR STEROIDS类固醇(甾类化合物)测定法<361> BARBITURATE ASSAY 巴比妥类药物测定法<371>COBALAMIN RADIOTRACER ASSAY钴铵素放射性跟踪剂测定法<381>ELASTOMERIC CLOSURES FOR INJECTIONS 注射剂的弹性密封件<391>EPINEPHRINE ASSAY肾上腺素测定法<401>FATS AND FIXED OILS脂肪与混合油<411>FOLIC ACID ASSAY叶酸测定法<413>IMPURITIES TESTING IN MEDICAL GASES 医用气体杂质检查<415>MEDICAL GASES ASSAY 医用气体含量检查<425>IODOMETRIC ASSAY—ANTIBIOTICS碘量检查法-抗生素<429>LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE粒径的光衍射测量法<431>METHOXY DETERMINATION甲氧基测定法<441>NIACIN OR NIACINAMIDE ASSAY 烟酰或烟酰胺测定法<451>NITRITE TITRATION亚硝酸盐滴定<461>NITROGEN DETERMINATION氮测定法<466>ORDINARY IMPURITIES一般杂质<467>RESIDUAL SOLVENTS残留溶剂<469>ETHYLENE GLYCOL, DIETHYLENE GLYCOL, AND TRIETHYLENE GLYCOL IN ETHOXYLATED SUBSTANCES乙氧基物质中乙二醇、二甘醇、三甘醇测定<471>OXYGEN FLASK COMBUSTION氧瓶燃烧法<481>RIBOFLAVIN ASSAY核黄素(维生素B2)测定法<501>SALTS OF ORGANIC NITROGENOUS BASES有机氮盐<503>ACETIC ACID IN PEPTIDES 多肽类中乙酸测定<511>SINGLE-STEROID ASSAY单一的类固醇测定法<525>SULFUR DIOXIDE 二氧化硫<531>THIAMINE ASSAY硫胺素测定法<541>TITRIMETRY滴定法<551>VITAMIN E ASSAY维生素E测定法<561>ARTICLES OF BOTANICAL ORIGIN植物起源的药品<563>IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN植物药品的鉴别<565>BOTANICAL EXTRACTS植物提取<571>VITAMIN A ASSAY维生素A测定法<581>VITAMIN D ASSAY维生素D测定法<591>ZINC DETERMINATION锌的测定法Physical Test and Determinations物理检查与测定法<601>INHALATION AND NASAL DRUG PRODUCTS: AEROSOLS, SPRAYS, AND POWDERS—PERFORMANCE QUALITY TESTS吸入剂、鼻雾剂:气溶胶,喷雾,干粉-质量通则<602>PROPELLANTS 推进剂<603>TOPICAL AEROSOLS 局部喷雾剂<604>LEAK RATE 渗漏率<610>ALTERNATIVE MICROBIOLOGICAL SAMPLING METHODS FOR NONSTERILE INHALED AND NASAL PRODUCTS非无菌吸入和鼻雾剂可供选择的微生物取样方法<611>ALCOHOL DETERMINATION乙醇测定法<616>BULK DENSITY AND TAPPED DENSITY堆密度与振实密度<621>CHROMATOGRAPHY色谱法<631>COLOR AND ACHROMICITY呈色与消色<641>COMPLETENESS OF SOLUTION溶解度<643>TOTAL ORGANIC CARBON总有机碳<645>W ATER CONDUCTIVITY水电导率<651>CONGEALING TEMPERATURE凝点温度<659>PACKAGING AND STORAGE REQUIREMENTS 包装和储藏要求<660>CONTAINERS—GLASS 容器-玻璃<661>CONTAINERS—PLASTICS容器-塑料<670>AUXILIARY PACKAGING COMPONENTS 辅助包装部件<671>CONTAINERS—PERFORMANCE TESTING容器-性能测试<691>COTTON棉花<695>CRYSTALLINITY结晶度<696>CHARACTERIZATION OF CRYSTALLINE SOLIDS BY MICROCALORIMETRY AND SOLUTION CALORIMETRY 通过溶液量热学测定结晶性<697>CONTAINER CONTENT FOR INJECTIONS 注射剂容器容积<698>DELIVERABLE VOLUME抽取体积<699>DENSITY OF SOLIDS固体密度<701>DISINTEGRATION崩解时限<705>QUALITY ATTRIBUTES OF TABLETS LABELED AS HA VING A FUNCTIONAL SCORE ?<711>DISSOLUTION 溶出度<721>DISTILLING RANGE馏程<724>DRUG RELEASE药物释放度<729>GLOBULE SIZE DISTRIBUTION IN LIPID INJECTABLE EMULSIONS脂类可注射的乳剂的粒径分布<730>Plasma Spectrochemistry 血浆光谱化学?<731>LOSS ON DRYING4干燥失重<733>LOSS ON IGNITION灼烧失重<735>X-RAY FLUORESCENCE SPECTROMETRY X射线光谱<736>MASS SPECTROMETRY 质谱<741>MELTING RANGE OR TEMPERATURE熔距或熔点<751>METAL PARTICLES IN OPHTHALMIC OINTMENTS眼用软膏中的金属粒子<755>MINIMUM FILL最低装量<761>NUCLEAR MAGNETIC RESONANCE核磁共振<771>OPHTHALMIC OINTMENTS眼用软膏<776>OPTICAL MICROSCOPY光学显微镜<781>OPTICAL ROTATION旋光度<785>OSMOLALITY AND OSMOLARITY渗透压<786>PARTICLE SIZE DISTRIBUTION ESTIMATION BY ANALYTICAL SIEVING 筛分法估算粒径分布<787>SUBVISIBLE PARTICULATE MATTER IN THERAPEUTIC PROTEIN INJECTIONS显微计数法在治疗性蛋白注射剂中应用<788>PARTICULATE MATTER IN INJECTIONS注射剂中的不溶性微粒<789>PARTICULATE MATTER IN OPHTHALMIC SOLUTIONS眼用溶液中的不溶性微粒<790>VISIBLE PARTICULATES IN INJECTIONS 注射剂中可见异物<791>pH<795>PHARMACEUTICAL COMPOUNDING—NONSTERILE PREPARATIONS药物混合-非无菌制剂<797>PHARMACEUTICAL COMPOUNDING—STERILE PREPARATIONS药物混合-无菌制剂<801>POLAROGRAPHY极谱法<811>POWDER FINENESS粉剂细度<821>RADIOACTIVITY放射性<823>POSITRON EMISSION TOMOGRAPHY DRUGS FOR COMPOUNDING, INVESTIGATIONAL, AND RESEARCH USES用于正电子发射断层造影术的放射性药物<831>REFRACTIVE INDEX折光率<841>SPECIFIC GRAVITY比重<846>SPECIFIC SURFACE AREA 比表面积<851>SPECTROPHOTOMETRY AND LIGHT-SCATTERING分光光度计与光散射<852>ATOMIC ABSORPTION SPECTROSCOPY 原子吸收光谱<853>FLUORESCENCE SPECTROSCOPY 荧光光谱<854>MID-INFRARED SPECTROSCOPY 中红外光谱<857>ULTRAVIOLET-VISIBLE SPECTROSCOPY 紫外可见光谱<861>SUTURES—DIAMETER缝线-直径?<871>SUTURES—NEEDLE ATTACHMENT缝线-穿孔实验<881>TENSILE STRENGTH张力<891>THERMAL ANALYSIS热分析<905>UNIFORMITY OF DOSAGE UNITS制剂单位的含量均匀度<911>VISCOSITY—CAPILLARY METHODS黏度-毛细管法<912>VISCOSITY—ROTATIONAL METHODS 黏度-旋转法<913>VISCOSITY—ROLLING BALL METHOD 黏度-球法<921>W ATER DETERMINATION水分测定<941>CHARACTERIZATION OF CRYSTALLINE AND PARTIALLY CRYSTALLINE SOLIDS BY X-RAY POWDER DIFFRACTION (XRPD)X光衍射General Information通用信息<1005>ACOUSTIC EMISSION 声频发射<1010>ANALYTICAL DATA—INTERPRETATION AND TREATMENT分析数据-解释与处理<1015>AUTOMATED RADIOCHEMICAL SYNTHESIS APPARATUS放射性自动合成装置<1024>BOVINE SERUM 牛血清<1027>FLOW CYTOMETRY 流式细胞仪<1030>BIOLOGICAL ASSAY CHAPTERS—OVERVIEW AND GLOSSARY生物测定章节-综述和术语<1031>THE BIOCOMPATIBILITY OF MATERIALS USED IN DRUG CONTAINERS, MEDICAL DEVICES, AND IMPLANTS用于药物容器、医疗设施和植入剂的材料的生物相容性<1034>ANALYSIS OF BIOLOGICAL ASSAYS 生物测定分析<1035>BIOLOGICAL INDICATORS FOR STERILIZATION灭菌用生物指示剂<1041>BIOLOGICS生物制剂<1043>Ancillary Material for Cell, Gene, and Tissue-Engineered Products细胞,基因与组织设计产品的辅助材料<1044>CRYOPRESERV ATION OF CELLS 细胞低温保存<1045>BIOTECHNOLOGY-DERIVED ARTICLES生物技术提取产品<1046>CELLULAR AND TISSUE-BASED PRODUCTS细胞与组织产品<1047>GENE THERAPY PRODUCTS 基因治疗产品<1048>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r-DNA DERIVED PROTEIN PRODUCTS 生物技术产品的质量:从蛋白质产品中提取的r-DNA产品在细胞中表达结构的分析<1049>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS生物技术产品的质量:生物技术/生物产品的稳定性实验<1050>VIRAL SAFETY EV ALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN从人或动物细胞中提取的生物技术产品的病毒安全性评估<1051>CLEANING GLASS APPARATUS玻璃容器的清洗<1052>BIOTECHNOLOGY-DERIVED ARTICLES—AMINO ACID ANALYSIS生物技术提取法-氨基酸测定<1053>CAPILLARY ELECTROPHORESIS 毛细管电泳法<1054>BIOTECHNOLOGY-DERIVED ARTICLES—ISOELECTRIC FOCUSING生物技术提取法-等电点聚集<1055>BIOTECHNOLOGY-DERIVED ARTICLES—PEPTIDE MAPPING生物技术提取法-肽谱<1056>BIOTECHNOLOGY-DERIVED ARTICLES—POLYACRYLAMIDE GEL ELECTROPHORESIS 生物技术提取法-凝胶电泳<1057>BIOTECHNOLOGY-DERIVED ARTICLES—TOTAL PROTEIN ASSAY生物技术提取法-总蛋白测定<1058>ANALYTICAL INSTRUMENT QUALIFICATION 分析仪器要求<1059>EXCIPIENT PERFORMANCE 赋形剂<1061>COLOR—INSTRUMENTAL MEASUREMENT显色-仪器测量<1065>Ion Chromatography 离子色谱法<1066>PHYSICAL ENVIRONMENTS THAT PROMOTE SAFE MEDICATION USE物理环境促使安全使用药物<1072>DISINFECTANTS AND ANTISEPTICS 消毒剂和防腐剂<1074>EXCIPIENT BIOLOGICAL SAFETY EV ALUATION GUIDELINES赋形剂(辅料)生物安全性评估指导<1078>GOOD MANUFACTURING PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS 批药品赋形剂的生产管理规范<1079>Good Storage and Shipping Practices 良好的贮存与运输规范<1080>BULK PHARMACEUTICAL EXCIPIENTS—CERTIFICATE OF ANALYSIS批药品赋形剂-COA<1084>GLYCOPROTEIN AND GLYCAN ANALYSIS—GENERAL CONSIDERATIONS 糖蛋白和多糖分析-一般通则<1086>IMPURITIES IN DRUG SUBSTANCES AND DRUG PRODUCTS药物和药物产品中的杂质<1087>APPARENT INTRINSIC DISSOLUTION—DISSOLUTION TESTING PROCEDURES FOR ROTATING DISK AND STATIONARY DISK内部的溶出度-旋转和静止溶出检测程序?<1088>IN VITRO AND IN VIVO EV ALUATION OF DOSAGE FORMS体内与体外的剂型的评估<1090>ASSESSMENT OF DRUG PRODUCT PERFORMANCE-BIOAV AILABILITY, BIOEQUIV ALENCE, AND DISSOLUTION药物产品性能评估:生物利用度、生物等效性和溶出<1091>LABELING OF INACTIVE INGREDIENTS非活性成分的标示<1092>THE DISSOLUTION PROCEDURE: DEVELOPMENT AND V ALIDATION溶出程序:开发与验证<1094>CAPSULES—DISSOLUTION TESTING AND RELATED QUALITY ATTRIBUTES 胶囊-关于产品质量的溶出测定<1097>BULK POWDER SAMPLING PROCEDURES:粉末样品取样程序<1102>IMMUNOLOGICAL TEST METHODS—GENERAL CONSIDERATIONS免疫测试方法-总则<1103>IMMUNOLOGICAL TEST METHODS—ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 免疫学测试方法-酶联免疫吸附测定<1104>IMMUNOLOGICAL TEST METHODS—IMMUNOBLOT ANALYSIS免疫测试方法-免疫印迹法<1105>IMMUNOLOGICAL TEST METHODS—SURFACE PLASMON RESONANCE 免疫测试方法-表面等离子体共振<1106>IMMUNOGENICITY ASSAYS—DESIGN AND VALIDATION OF IMMUNOASSAYS TO DETECT ANTI-DRUG ANTIBODIES?<1111>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: ACCEPTANCE CRITERIA FOR PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL USE非无菌产品的微生物学检查:药用制剂和制药过程使用的物质接受标准<1112>MICROBIAL CHARACTERIZATION, IDENTIFICATION, AND STRAIN TYPING 非无菌药物产品水活性测定应用<1113>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE PHARMACEUTICAL PRODUCTS 非无菌药品中的微生物分布<1115>BIOBURDEN CONTROL OF NONSTERILE DRUG SUBSTANCES AND PRODUCTS 非无菌药物和产品的生物负载控制<1116>MICROBIOLOGICAL CONTROL AND MONITORING OF ASEPTIC PROCESSING ENVIRONMENTS洁净的房间与其它可控环境的微生物评估<1117>MICROBIOLOGICAL BEST LABORATORY PRACTICES 微生物最优实验室规范<1118>MONITORING DEVICES—TIME, TEMPERATURE, AND HUMIDITY监控装置-时间、温度与湿度<1119>NEAR-INFRARED SPECTROPHOTOMETRY近红外分光光度测定法<1120>Raman Spectrophotometry 拉曼分光光度测定法<1121>NOMENCLATURE命名<1125>NUCLEIC ACID-BASED TECHNIQUES—GENERAL 核酸技术-通则<1126>NUCLEIC ACID-BASED TECHNIQUES—EXTRACTION, DETECTION, AND SEQUENCING 核酸技术-提取、检测、测序<1127>NUCLEIC ACID-BASED TECHNIQUES—AMPLIFICATION 核酸技术-扩增<1128>NUCLEIC ACID-BASED TECHNIQUES—MICROARRAY 核酸技术-微阵列<1129>NUCLEIC ACID-BASED TECHNIQUES—GENOTYPING 核酸技术-基因分型<1130>NUCLEIC ACID-BASED TECHNIQUES—APPROACHES FOR DETECTING TRACE NUCLEIC ACIDS (RESIDUAL DNA TESTING)核酸技术-探测微量核酸的应用(残留DNA测试)<1136>PACKAGING AND REPACKAGING—SINGLE-UNIT CONTAINERS包装和再包装-单一容器<1151>PHARMACEUTICAL DOSAGE FORMS药物剂型<1152>ANIMAL DRUGS FOR USE IN ANIMAL FEEDS兽药在动物饲料中的使用<1160>PHARMACEUTICAL CALCULATIONS IN PRESCRIPTION COMPOUNDING 按处方混合的药物的计算<1163>QUALITY ASSURANCE IN PHARMACEUTICAL COMPOUNDING按处方混合的药物的质量保证<1171>PHASE-SOLUBILITY ANALYSIS相溶解分析<1174>Powder Flow 粉末流动性<1176>PRESCRIPTION BALANCES AND VOLUMETRIC APPARATUS 处方天平与容量器具<1177>Good Packaging Practices 良好的包装操作<1178>Good Repackaging Practices 良好的再包装操作<1180>HUMAN PLASMA 人血浆<1181>SCANNING ELECTRON MICROSCOPY扫描电子显微镜<1184>SENSITIZATION TESTING 致敏测试<1191>STABILITY CONSIDERATIONS IN DISPENSING PRACTICE分装操作中稳定性考察<1195>SIGNIFICANT CHANGE GUIDE FOR BULK PHARMACEUTICAL EXCIPIENTS 散装药用辅料更换指导原则<1197>GOOD DISTRIBUTION PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS 散装药用辅料良好的分装操作<1207>STERILE PRODUCT PACKAGING—INTEGRITY EV ALUATION无菌产品包装-完整性评估<1208>STERILITY TESTING—V ALIDATION OF ISOLATOR SYSTEMS无菌实验-隔离系统的验证<1209>STERILIZATION—CHEMICAL AND PHYSICOCHEMICAL INDICATORS AND INTEGRATORS灭菌-化学与物理化学的指示剂以及二者的综合<1211>STERILIZATION AND STERILITY ASSURANCE OF COMPENDIAL ARTICLES 药典物品中的灭菌与灭菌保证<1216>TABLET FRIABILITY片剂的脆碎度<1217>TABLET BREAKING FORCE 片剂断裂力<1222>TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE 药品终端灭菌-放行参数<1223>V ALIDATION OF ALTERNATIVE MICROBIOLOGICAL METHODS可供选择的微生物学方法的验证<1224>TRANSFER OF ANALYTICAL PROCEDURES 分析方法转移<1225>V ALIDATION OF COMPENDIAL PROCEDURES药典方法的验证<1226>VERIFICATION OF COMPENDIAL PROCEDURES 药典方法的确认<1227>V ALIDATION OF MICROBIAL RECOVERY FROM PHARMACOPEIAL ARTICLES从药物中回收微生物的验证<1229>STERILIZATION OF COMPENDIAL ARTICLES 药典灭菌过程<1229.1>STEAM STERILIZATION BY DIRECT CONTACT 直接蒸汽灭菌<1229.2>MOIST HEAT STERILIZATION OF AQUEOUS LIQUIDS 水溶液的湿热灭菌<1229.3>MONITORING OF BIOBURDEN 生物负载监控<1229.4>STERILIZING FILTRATION OF LIQUIDS 溶液的无菌过滤器<1229.6>LIQUID-PHASE STERILIZATION 液态灭菌<1229.7>GASEOUS STERILIZATION 气态灭菌<1229.8>DRY HEAT STERILIZATION 干热灭菌<1229.10>RADIATION STERILIZATION 辐射灭菌<1230>W ATER FOR HEMODIALYSIS APPLICATIONS 血液透析过程用水<1231>W ATER FOR PHARMACEUTICAL PURPOSES制药用水<1234>VACCINES FOR HUMAN USE—POLYSACCHARIDE AND GLYCOCONJUGATE VACCINES 人用疫苗-多糖和糖复合物疫苗<1235>V ACCINES FOR HUMAN USE—GENERAL CONSIDERATIONS 人用疫苗-通则<1237>VIROLOGY TEST METHODS 病毒测试方法<1238>V ACCINES FOR HUMAN USE—BACTERIAL V ACCINES 人用疫苗-细菌疫苗<1240>VIRUS TESTING OF HUMAN PLASMA FOR FURTHER MANUFACTURE下一步使用人血浆的病毒测试<1241>W ATER–SOLID INTERACTIONS IN PHARMACEUTICAL SYSTEMS在药物系统中水与固体的相互作用<1251>WEIGHING ON AN ANALYTICAL BALANCE关于分析天平的称重<1265>Written Prescription Drug Information-Guidelines 书面的处方药信息-指南<1285>PREPARATION OF BIOLOGICAL SPECIMENS FOR HISTOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS为了组织和免疫组织分析的生物标本制备<1285.1>HEMATOXYLIN AND EOSIN STAINING OF SECTIONED TISSUE FOR MICROSCOPIC EXAMINATION显微镜观察用苏木精和伊红染色的切片<1601>PRODUCTS FOR NEBULIZATION—CHARACTERIZATION TESTS 产品雾化状态-性状描述<1644>THEORY AND PRACTICE OF ELECTRICAL CONDUCTIVITY MEASUREMENTS OF SOLUTIONS溶液电导值测量方法的理论与实践<1660>EV ALUATION OF THE INNER SURFACE DURABILITY OF GLASS CONTAINERS 玻璃容器内表面耐久性评估<1724>SEMISOLID DRUG PRODUCTS—PERFORMANCE TESTS 半固态药物产品-性能测试<1736>APPLICATIONS OF MASS SPECTROMETRY 质谱应用<1761>APPLICATIONS OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY核磁共振光谱应用<1787>MEASUREMENT OF SUBVISIBLE PARTICULATE MATTER IN THERAPEUTIC PROTEIN INJECTIONS用显微镜测量方法测量治疗性蛋白注射剂的不溶性微粒<1788>METHODS FOR THE DETERMINATION OF PARTICULATE MATTER IN INJECTIONS AND OPHTHALMIC SOLUTIONS注射剂和眼用溶液的不溶性微粒测定的方法选择<1852>ATOMIC ABSORPTION SPECTROSCOPY—THEORY AND PRACTICE原子吸收光谱-理论与实践<1853>FLUORESCENCE SPECTROSCOPY—THEORY AND PRACTICE荧光光谱-理论与实践<1854>MID-INFRARED SPECTROSCOPY—THEORY AND PRACTICE中红外光谱-理论与实践<1857>ULTRA VIOLET-VISIBLE SPECTROSCOPY—THEORY AND PRACTICE紫外可见光谱-理论与实践<1911>RHEOMETRY 流变测定Dietary Supplements营养补充剂General Tests and Assays 一般检查法与测定法<2021>MICROBIAL ENUMERATION TESTS—NUTRITIONAL AND DIETARY SUPPLEMENTS…3080微生物数量实验-营养与食品添加剂<2022>MICROBIOLOGICAL PROCEDURES FOR ABSENCE OF SPECIFIED MICROORGANISMS—NUTRITIONAL AND DIETARY SUPPLEMENTS (3083)不得检出特定微生物的程序-营养与营养补充剂<2023>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE NUTRITIONAL AND DIETARY SUPPLEMENTS……3087非无菌的营养与食品添加剂中的微生物分布<2040>DISINTEGRATION AND DISSOLUTION OF DIETARY SUPPLEMENTS (3089)食品添加剂的崩解与溶出<2091>WEIGHT V ARIATION OF DIETARY SUPPLEMENTS……3092食品添加剂的重量差异<2750>MANUFACTURING PRACTICES FOR DIETARY SUPPLEMENTS (3093)食品添加剂的生产操作。
USP40-NF35通用章节目录
Guide to General Chapters 通用章节指导(标注底色部分为USP40-NF35新增章节)General Requirements for Test and Assays 检查与含量分析的一般要求<1>INJECTIONS AND IMPLANTED DRUG PRODUCTS (PARENTERALS)—PRODUCT QUALITY TESTS 注射和植入药物产品(注射用) —产品质量测试<1>INJECTIONS 注射剂<2>ORAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 口服药物产品质量测试<3>TOPICAL AND TRANSDERMAL DRUG PRODUCTS—PRODUCT QUALITY TESTS局部和透皮药物产品—产品质量测试<4>MUCOSAL DRUG PRODUCTS—PRODUCT QUALITY TESTS 粘膜药物产品质量测试<5>INHALATION AND NASAL DRUG PRODUCTS—GENERAL INFORMATION AND PRODUCT QUALITY TESTS 吸入剂产品—产品质量测试<7>LABELING 标签<11>USP REFERENCE STANDARDS USP标准品Apparatus for Test and Assays 用于检查与含量分析的器具<17>PRESCRIPTION CONTAINER LABELING 处方容器标签<21>THERMOMETERS 温度计(本版本已删除)<31>VOLUMETRIC APPARATUS 容量器具<41>BALANCES 天平Microbiological Tests 微生物检查法<51>ANTIMICROBIAL EFFECTIVENESS TESTING 抗菌剂有效性检查法<55>BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS生物指示剂-耐药性实验<61>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS 非无菌产品的微生物限度检查:微生物列举检查法<62>MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: TESTS FOR SPECIFIED MICROORGANISMS 非无菌产品的微生物限度检查:特定微生物检查法<63>MYCOPLASMA TESTS 支原体检查法<71>STERILITY TESTS 无菌检查法Biological tests and assays 生物检查法与测定法<81>ANTIBIOTICS—MICROBIAL ASSAYS 抗生素-微生物测定<85>BACTERIAL ENDOTOXINS TEST 细菌内毒素检查法<87>BIOLOGICAL REACTIVITY TESTS, IN VITRO 体外的生物反应性检查法<88>BIOLOGICAL REACTIVITY TESTS, IN VIVO 体内的生物反应性检查法<89>ENZYMES USED AS ANCILLARY MATERIALS IN PHARMACEUTICAL MANUFACTURING药品生产中酶作为辅料所使用<89.1> COLLAGENASEⅠ胶原酶Ⅰ<89.2> COLLAGENASEⅡ胶原酶Ⅱ<90>FETAL BOVINE SERUM—QUALITY ATTRIBUTES AND FUNCTIONALITY TESTS牛胎儿血清-质量品质和功能检查法<91>CALCIUM PANTOTHENATE ASSAY 泛酸钙测定法<92>GROWTH FACTORS AND CYTOKINES USED IN CELL THERAPY MANUFACTURING在细胞疗法中使用生长因子和细胞因子<111>DESIGN AND ANALYSIS OF BIOLOGICAL ASSAYS 生物测定法的设计与分析<115>DEXPANTHENOL ASSAY右泛醇(拟胆碱药)测定法<121>INSULIN ASSAYS 胰岛素测定法<121.1>PHYSICOCHEMICAL ANALYTICAL PROCEDURES FORINSULINS胰岛素的物理化学分析程序<123>GLUCAGON BIOIDENTITY TESTS 高血糖素的生物鉴别检查法<124>ERYTHROPOIETIN BIOASSAYS 红细胞生成素的微生物测定<126>SOMATROPIN BIOIDENTITY TESTS 生长激素的生物鉴别检查法<127>FLOW CYTOMETRIC ENUMERATION OF CD34+ CELL 流式细胞术计术34阳性细胞<129>ANALYTICAL PROCEDURES FOR RECOMBINANT THERAPEUTIC MONOCLONAL ANTIBODIES重组治疗性单克隆抗体的分析方法<130>PROTEIN A QUALITY ATTRIBUTES 蛋白质A的质量特征<151>PYROGEN TEST 热原检查法<161>TRANSFUSION AND INFUSION ASSEMBLIES AND SIMILAR MEDICAL DEVICES输血输液用具以及相类似的医疗器械<162>DIPHTHERIA ANTITOXIN POTENCY TESTING FOR HUMAN IMMUNE GLOBULINS 人免疫球蛋白的白喉抗毒素效力检测<165>PREKALLIKREIN ACTIVATOR前激肽释放酶原激活剂<171>VITAMIN B12 ACTIVITY ASSAY……2548 维生素B12活性测定法Chemical Tests and assays 化学实验检查与测定法鉴别检查<181>IDENTIFICATION—ORGANIC NITROGENOUS BASES鉴别-有机氮碱化合物<191>IDENTIFICATION TESTS—GENERAL 鉴别实验-通用<193>IDENTIFICATION—TETRACYCLINES 鉴别-四环素类<197>SPECTROPHOTOMETRIC IDENTIFICATION TESTS 分光光度计鉴别实验<201>THIN-LAYER CHROMATOGRAPHIC IDENTIFICATION TEST 薄层色谱鉴别实验<202>IDENTIFICATION OF FIXED OILS BY THIN-LAYER CHROMATOGRAPHY 薄层色谱法对非挥发性油的鉴别<203>HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY PROCEDURE FOR IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN 高性能薄层色谱法对植物的鉴别Limit Tests 限度检查法<206>ALUMINUM 铝<207>TEST FOR 1,6-ANHYDRO DERIVATIVE FOR ENOXAPARIN SODIUM依诺肝素钠的酐类衍生物实验<208>ANTI-FACTOR Xa AND ANTI-FACTOR IIa ASSAYS FORUNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS 普通肝素和低分子肝素产品中抗体Xa和抗体IIa测定<209>LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS低分子肝素钠分子量测定<211>ARSENIC 砷<212>OLIGOSACCHARIDE ANALYSIS 低聚糖的分析<221>CHLORIDE AND SULFATE 氯和硫<223>DIMETHYLANILINE 二甲基苯胺<226>4-EPIANHYDRO-TETRACYCLINE 4-?-四环素<227>4-AMINOPHENOL IN ACETAMINOPHEN-CONTAINING DRUG PRODUCTS对乙酰氨酚药物产品中氨基酚<228>ETHYLENE OXIDE AND DIOXANE 环氧乙烷和二氧六环<231>HEAVY METALS 重金属(删除)<232>ELEMENTAL IMPURITIES—LIMITS 元素杂质-限度<233>ELEMENTAL IMPURITIES—PROCEDURES 元素杂质-规程<241>IRON 铁<251>LEAD 铅<261>MERCURY 汞<267>POROSIMETRY BY MERCURY INTRUSION 水银孔隙仪<268>POROSITY BY NITROGEN ADSORPTION–DESORPTION 氮吸附-解吸测定孔隙率<271>READILY CARBONIZABLE SUBSTANCES TEST 易碳化物检查法<281>RESIDUE ON IGNITION 炽灼残渣<291>SELENIUM 硒Other Tests and Assays 其它检查法与测定法<301>ACID-NEUTRALIZING CAPACITY 酸中和容量<311>ALGINATES ASSAY 藻酸盐测定法<341>ANTIMICROBIAL AGENTS—CONTENT 抗菌剂-含量<345>Assay for Citric Acid/Citrate and Phosphate 柠檬酸/柠檬酸盐和磷酸盐的测定<351>ASSAY FOR STEROIDS 类固醇(甾类化合物)测定法<361> BARBITURATE ASSAY 巴比妥类药物测定法(本版本已删除)<371>COBALAMIN RADIOTRACER ASSAY 钴铵素放射性跟踪剂测定法<381>ELASTOMERIC CLOSURES FOR INJECTIONS 注射剂的弹性密封件<391>EPINEPHRINE ASSAY 肾上腺素测定法<401>FATS AND FIXED OILS 脂肪与混合油<411>FOLIC ACID ASSAY 叶酸测定法<413>IMPURITIES TESTING IN MEDICAL GASES 医用气体杂质检查<415>MEDICAL GASES ASSAY 医用气体含量检查<425>IODOMETRIC ASSAY—ANTIBIOTICS 碘量检查法-抗生素<429>LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE 粒径的光衍射测量法<431>METHOXY DETERMINATION 甲氧基测定法<441>NIACIN OR NIACINAMIDE ASSAY 烟酰或烟酰胺测定法<451>NITRITE TITRATION 亚硝酸盐滴定<461>NITROGEN DETERMINATION 氮测定法<466>ORDINARY IMPURITIES 一般杂质<467>RESIDUAL SOLVENTS 残留溶剂<469>ETHYLENE GLYCOL, DIETHYLENE GLYCOL, AND TRIETHYLENE GLYCOL IN ETHOXYLATED SUBSTANCES乙氧基物质中乙二醇、二甘醇、三甘醇测定<471>OXYGEN FLASK COMBUSTION 氧瓶燃烧法<481>RIBOFLAVIN ASSAY 核黄素(维生素B2)测定法<501>SALTS OF ORGANIC NITROGENOUS BASES 有机氮盐<503>ACETIC ACID IN PEPTIDES 多肽类中乙酸测定<503.1>TRIFLUOROACETIC ACID(TFA)IN PEPTIDES 肽中三氟乙酸<507>PROTEIN DETERMINATION PROCEDURES 蛋白质测定程序<511>SINGLE-STEROID ASSAY 单一的类固醇测定法<525>SULFUR DIOXIDE 二氧化硫<531>THIAMINE ASSAY 硫胺素测定法<541>TITRIMETRY 滴定法<551>VITAMIN E ASSAY 维生素E测定法<561>ARTICLES OF BOTANICAL ORIGIN 植物起源的药品<563>IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN 植物药品的鉴别<565>BOTANICAL EXTRACTS 植物提取<571>VITAMIN A ASSAY 维生素A测定法<580>VITAMIN C ASSAY 维生素C的测定法<581>VITAMIN D ASSAY 维生素D测定法<591>ZINC DETERMINATION 锌的测定法Physical Test and Determinations 物理检查与测定法<601>INHALATION AND NASAL DRUG PRODUCTS: AEROSOLS, SPRAYS, AND POWDERS—PERFORMANCE QUALITY TESTS吸入剂、鼻雾剂:气溶胶,喷雾,干粉-质量通则<602>PROPELLANTS 推进剂<603>TOPICAL AEROSOLS 局部喷雾剂<604>LEAK RATE 渗漏率<610>ALTERNATIVE MICROBIOLOGICAL SAMPLING METHODS FOR NONSTERILE INHALED AND NASAL PRODUCTS非无菌吸入和鼻雾剂可供选择的微生物取样方法<611>ALCOHOL DETERMINATION 乙醇测定法<616>BULK DENSITY AND TAPPED DENSITY 堆密度与振实密度<621>CHROMATOGRAPHY 色谱法<631>COLOR AND ACHROMICITY 呈色与消色<641>COMPLETENESS OF SOLUTION 溶解度<643>TOTAL ORGANIC CARBON 总有机碳<645>WATER CONDUCTIVITY 水电导率<651>CONGEALING TEMPERATURE 凝点温度<659>PACKAGING AND STORAGE REQUIREMENTS 包装和储藏要求<660>CONTAINERS—GLASS 容器-玻璃<661>CONTAINERS—PLASTICS容器-塑料<661.1>PLASTIC MATERIALS OF CONSTRUCTION塑料包装材料<661.2>PLASTIC PACKAGING SYSTEMS FOR PHARMACEUTICAL USE药用塑料包装系统<670>AUXILIARY PACKAGING COMPONENTS 辅助包装部件<671>CONTAINERS—PERFORMANCE TESTING 容器-性能测试<691>COTTON 棉花<695>CRYSTALLINITY 结晶度<696>CHARACTERIZATION OF CRYSTALLINE SOLIDS BY MICROCALORIMETRY AND SOLUTION CALORIMETRY 通过溶液量热学测定结晶性<697>CONTAINER CONTENT FOR INJECTIONS 注射剂容器容积<698>DELIVERABLE VOLUME 抽取体积<699>DENSITY OF SOLIDS 固体密度<701>DISINTEGRATION 崩解时限<705>QUALITY ATTRIBUTES OF TABLETS LABELED AS HAVING A FUNCTIONAL SCORE?<711>DISSOLUTION 溶出度<721>DISTILLING RANGE 馏程<724>DRUG RELEASE 药物释放度<729>GLOBULE SIZE DISTRIBUTION IN LIPID INJECTABLE EMULSIONS脂类可注射的乳剂的粒径分布<730>Plasma Spectrochemistry 血浆光谱化学?<731>LOSS ON DRYING4 干燥失重<733>LOSS ON IGNITION 灼烧失重<735>X-RAY FLUORESCENCE SPECTROMETRY X射线光谱<736>MASS SPECTROMETRY 质谱<741>MELTING RANGE OR TEMPERATURE 熔距或熔点<751>METAL PARTICLES IN OPHTHALMIC OINTMENTS 眼用软膏中的金属粒子<755>MINIMUM FILL 最低装量<761>NUCLEAR MAGNETIC RESONANCE 核磁共振<771>OPHTHALMIC OINTMENTS 眼用软膏<776>OPTICAL MICROSCOPY 光学显微镜<781>OPTICAL ROTATION 旋光度<782>VIBRATIONAL CIRCULAR DICHROISM SPECTROSCOPY 振动圆二色谱<785>OSMOLALITY AND OSMOLARITY 渗透压<786>PARTICLE SIZE DISTRIBUTION ESTIMATION BY ANALYTICAL SIEVING筛分法估算粒径分布<787>SUBVISIBLE PARTICULATE MATTER IN THERAPEUTIC PROTEIN INJECTIONS显微计数法在治疗性蛋白注射剂中应用<788>PARTICULATE MATTER IN INJECTIONS 注射剂中的不溶性微粒<789>PARTICULATE MATTER IN OPHTHALMIC SOLUTIONS 眼用溶液中的不溶性微粒<790>VISIBLE PARTICULATES IN INJECTIONS 注射剂中可见异物<791>pH<795>PHARMACEUTICAL COMPOUNDING—NONSTERILE PREPARATIONS药物混合-非无菌制剂<797>PHARMACEUTICAL COMPOUNDING—STERILE PREPARATIONS药物混合-无菌制剂<800>HAZARDOUS DRUGS—HANDLING IN HEALTHCARE SETTINGS 在医疗环境中危险药品的处理<801>POLAROGRAPHY 极谱法<811>POWDER FINENESS 粉剂细度<821>RADIOACTIVITY 放射性<823>POSITRON EMISSION TOMOGRAPHY DRUGS FOR COMPOUNDING, INVESTIGATIONAL, AND RESEARCH USES用于正电子发射断层造影术的放射性药物<831>REFRACTIVE INDEX 折光率<841>SPECIFIC GRAVITY 比重<846>SPECIFIC SURFACE AREA 比表面积<851>SPECTROPHOTOMETRY AND LIGHT-SCATTERING 分光光度计与光散射(本版本已删除)<852>ATOMIC ABSORPTION SPECTROSCOPY 原子吸收光谱<853>FLUORESCENCE SPECTROSCOPY 荧光光谱<854>MID-INFRARED SPECTROSCOPY 中红外光谱<855>NEPHELOMETRY, TURBIDIMETRY, AND VISUAL COMPARISO 浊度测定、比浊法、视觉比较<857>ULTRAVIOLET-VISIBLE SPECTROSCOPY 紫外可见光谱<861>SUTURES—DIAMETER 缝线-直径?<871>SUTURES—NEEDLE ATTACHMENT 缝线-穿孔实验<881>TENSILE STRENGTH 张力<891>THERMAL ANALYSIS 热分析<905>UNIFORMITY OF DOSAGE UNITS 制剂单位的含量均匀度<911>VISCOSITY—CAPILLARY METHODS 黏度-毛细管法<912>VISCOSITY—ROTATIONAL METHODS 黏度-旋转法<913>VISCOSITY—ROLLING BALL METHOD 黏度-球法<914>VISCOSITY—PRESSURE DRIVEN METHODS 黏度-压力驱动方法<921>WATER DETERMINATION 水分测定<941>CHARACTERIZATION OF CRYSTALLINE AND PARTIALLY CRYSTALLINE SOLIDS BY X-RAY POWDER DIFFRACTION(XRPD) X光衍射General Information 通用信息<1004>MUCOSAL DRUG PRODUCTS—PERFORMANCE TESTS粘膜药物产品性能测试<1005>ACOUSTIC EMISSION 声频发射<1010>ANALYTICAL DATA—INTERPRETATION AND TREATMENT 分析数据-解释与处理<1015>AUTOMATED RADIOCHEMICAL SYNTHESIS APPARATUS 放射性自动合成装置<1024>BOVINE SERUM 牛血清<1025>PANCREATIN胰液素<1027>FLOW CYTOMETRY 流式细胞仪<1029>GOOD DOCUMENTATION GUIDELINES 好的文件指南<1030>BIOLOGICAL ASSAY CHAPTERS—OVERVIEW AND GLOSSARY生物测定章节-综述和术语<1031>THE BIOCOMPATIBILITY OF MATERIALS USED IN DRUG CONTAINERS, MEDICAL DEVICES, AND IMPLANTS用于药物容器、医疗设施和植入剂的材料的生物相容性<1032>DESIGN AND DEVELOPMENT OF BIOLOGICAL ASSAYS 生物试验的设计和开发<1033>BIOLOGICAL ASSAY VALIDATION 生物试验的验证<1034>ANALYSIS OF BIOLOGICAL ASSAYS 生物测定分析<1035>BIOLOGICAL INDICATORS FOR STERILIZATION 灭菌用生物指示剂(本版本已删除)<1039>CHEMOMETRICS 化学<1041>BIOLOGICS 生物制剂<1043>Ancillary Material for Cell, Gene, and Tissue-Engineered Products细胞,基因与组织设计产品的辅助材料<1044>CRYOPRESERVATION OF CELLS 细胞低温保存<1045>BIOTECHNOLOGY-DERIVED ARTICLES 生物技术提取产品(本版本已删除)<1046>CELLULAR AND TISSUE-BASED PRODUCTS 细胞与组织产品<1047>GENE THERAPY PRODUCTS 基因治疗产品<1048>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r-DNA DERIVED PROTEIN PRODUCTS生物技术产品的质量:从蛋白质产品中提取的r-DNA产品在细胞中表达结构的分析<1049>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICALPRODUCTS生物技术产品的质量:生物技术/生物产品的稳定性实验<1050>VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMALORIGIN从人或动物细胞中提取的生物技术产品的病毒安全性评估<1050.1>DESIGN, EVALUATION,AND CHARACTERIZATION OF VIRAL CLEARANCE PROCEDURES 病毒清除过程的设计、评估和鉴定。
美国药典USP32-重金属测试
<231> 重金属本试验系在规定的试验条件下,金属离子与硫化物离子反应显色,通过制备的标准铅溶液目视比较测定,以确证供试品中重金属杂质含量不超过各论项下规定的限度(以供试品中铅的百分比表示,以重量计)。
(见分光光度法和光散射项下测定法目视比较法<851>)[ 注意:对本试验有响应的典型物质有铅、汞、铋、砷、锑、锡、镉、银、铜和钼等]。
除各论另有规定外,按第一法测定重金属。
第一法适用于在规定试验条件下,能产生澄清、无色溶液的物质。
第二法适用于在第一法规定试验条件下不能产生澄清、无色溶液的物质,或者适用于由于性质复杂,易干扰硫化物离子与金属离子形成沉淀的物质,或者是不易挥发的和易挥发的油类物质。
第三法为湿消化法,仅用于第一法、第二法都不适合的情况。
特殊试剂特殊试剂特殊试剂特殊试剂硝酸铅贮备液—取硝酸铅159.8mg,溶于100ml水中,加1ml硝酸,用水稀释至1000ml。
制备和贮存本溶液的玻璃容器应不含可溶性铅。
标准铅溶液—使用当天,取硝酸铅贮备液10.0ml,用水稀释至100.0ml。
每1ml的标准铅溶液含相当于10µg的铅。
按每克供试品取100µl标准铅溶液制备的对照溶液,相当于供试品含百万分之一的铅。
方法方法方法方法IIII pH3.5醋酸盐缓冲液—取醋酸铵25.0g溶于25ml水中,加6N盐酸液38.0ml,必要时,用6N氢氧化铵液或6N盐酸液调节pH至3.5,用水稀释至100ml,混匀。
标准溶液准备—精密量取标准铅溶液2ml,(相当于20µg的Pb),置50ml比色管中,加水稀释至25ml,以精密pH试纸作为外指示剂,用1N醋酸液或6N 氢氧化铵液调节pH至3.0~4.0,用水稀释至40ml,混匀。
供试品溶液制备—取各论项下规定的供试品溶液25ml,置50ml比色管中,或用各论项下规定用量的酸溶解样品,再用水稀释至25ml,供试品以g计,按下式计算: 2.0/(1000L)式中L是重金属限度(%)。
美国药典USP39版元素杂质 232 ELEMENTAL IMPURITIES-LIMITS
Method III pH 3.5 Acetate Buffer—Prepare as directed under Method I.Standard Preparation—Transfer a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid to a clean, dry, 100-mL Kjeldahl flask, and add a further volume of nitric acid equal to the incremental volume of nitric acid added to the Test Preparation . Heat the solution to the production of dense, white fumes; cool; cautiously add 10 mL of water; and, if hydrogen peroxide was used in treating the Test Preparation , add a volume of 30 percent hydrogen peroxide equal to that used for the substance be-ing tested. Boil gently to the production of dense, white fumes. Again cool, cautiously add 5 mL of water, mix, and boil gently to the production of dense, white fumes and to a volume of 2 to 3 mL. Cool, dilute cautiously with a few mL of water, add 2.0mL of Standard Lead Solution (20 m g of Pb), and mix. Transfer to a 50-mL color-comparison tube, rinse the flask with water,adding the rinsing to the tube until the volume is 25 mL, and mix.Test Preparation—Unless otherwise indicated in the individual monograph, use a quantity, in g, of the substance to be tested as calculated by the formula:2.0/(1000L)in which L is the Heavy metals limit, as a percentage.If the substance is a solid—Transfer the weighed quantity of the test substance to a clean, dry, 100-mL Kjeldahl flask.[NOTE —A 300-mL flask may be used if the reaction foams excessively.] Clamp the flask at an angle of 45°, and add a sufficient quantity of a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid to moisten the substance thoroughly. Warm gently until the reaction commences, allow the reaction to subside, and add portions of the same acid mixture, heating after each addi-tion, until a total of 18 mL of the acid mixture has been added. Increase the amount of heat, and boil gently until the solutiondarkens. Cool, add 2 mL of nitric acid, and heat again until the solution darkens. Continue the heating, followed by addition ofnitric acid until no further darkening occurs, then heat strongly to the production of dense, white fumes. Cool, cautiously add 5 mL of water, boil gently to the production of dense, white fumes, and continue heating until the volume is reduced to a fewmL. Cool, cautiously add 5 mL of water, and examine the color of the solution. If the color is yellow, cautiously add 1 mL of 30percent hydrogen peroxide, and again evaporate to the production of dense, white fumes and a volume of 2 to 3 mL. If thesolution is still yellow, repeat the addition of 5 mL of water and the peroxide treatment. Cool, dilute cautiously with a few mL of water, and rinse into a 50-mL color-comparison tube, taking care that the combined volume does not exceed 25 mL.If the substance is a liquid—Transfer the weighed quantity of the test substance to a clean, dry, 100-mL Kjeldahl flask.[N OTE —A 300-mL flask may be used if the reaction foams excessively.] Clamp the flask at an angle of 45°, and cautiously add a few mL of a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid. Warm gently until the reaction commences, allow the reaction to subside, and proceed as directed for If the substance is a solid , beginning with “add portions of the same acid mix-ture.”Monitor Preparation—Proceed with the digestion, using the same amount of sample and the same procedure as directed in the subsection If the substance is a solid in the section Test Preparation , until the step “Cool, dilute cautiously with a few mL of water.” Add 2.0 mL of Lead Standard Solution (20 m g of lead), and mix. Transfer to a 50-mL color comparison tube, rinse the flask with water, adding the rinsing to the tube until the volume is 25 mL, and mix.Procedure—Treat the Test Preparation , the Standard Preparation , and the Monitor Preparation as follows. Using a pH meter or short-range pH indicator paper as external indicator, adjust the solution to a pH between 3.0 and 4.0 with ammonium hy-droxide (a dilute ammonia solution may be used, if desired, as the specified range is approached), dilute with water to 40 mL,and mix.To each tube add 2 mL of pH 3.5 Acetate Buffer , then add 1.2 mL of thioacetamide–glycerin base TS, dilute with water to 50mL, mix, allow to stand for 2 minutes, and view downward over a white surface*: the color of the Test Preparation is not darker than that of the Standard Preparation , and the color of the Monitor Preparation is equal to or darker than that of the Standard Preparation .Official:January 1, 2018(RB 1-Apr-2015)(Official 1-Jan-2018)á232ñ ELEMENTAL IMPURITIES—LIMITSINTRODUCTIONThis general chapter specifies limits for the amounts of elemental impurities in drug products. Elemental impurities include catalysts and environmental contaminants that may be present in drug substances, excipients, or drug products. These impuri-ties may occur naturally, be added intentionally, or be introduced inadvertently (e.g., by interactions with processing equip-ment and the container closure system). When elemental impurities are known to be present, have been added, or have the potential for introduction, assurance of compliance to the specified levels is required. A risk-based control strategy may be ap-268 á231ñ Heavy Metals / Chemical Tests USP 39propriate when analysts determine how to assure compliance with this standard. Due to the ubiquitous nature of arsenic, cad-mium, lead, and mercury, they (at the minimum) must be considered in the risk assessment. Regardless of the approach used, compliance with the limits specified is required for all drug products unless otherwise specified in an individual monograph or excluded in paragraph three of this introduction.The drug products containing purified proteins and polypeptides (including proteins and polypeptides produced from re-combinant or non-recombinant origins), their derivatives, and products of which they are components (e.g., conjugates) are within the scope of this chapter, as are drug products containing synthetically produced polypeptides, polynucleotides, and oligosaccharides.This chapter does not apply to radiopharmaceuticals, vaccines, cell metabolites, DNA products, allergenic extracts, cells, whole blood, cellular blood components or blood derivatives including plasma and plasma derivatives, dialysate solutions not intended for systemic circulation, and elements that are intentionally included in the drug product for therapeutic benefit. This chapter does not apply to products based on genes (gene therapy), cells (cell therapy), and tissue (tissue engineering).The limits presented in this chapter do not apply to excipients and drug substances, except where specified in this chapter or in the individual monograph. However, elemental impurity levels present in drug substances and excipients must be known, documented, and made available upon request.This chapter does not apply to articles intended only for veterinary use. Requirements listed in this chapter also do not apply to total parenteral nutritions (TPNs) and dialysates. Dietary supplements and their ingredients are addressed in Elemental Con-taminants in Dietary Supplements á2232ñ.SPECIATIONThe determination of the oxidation state, organic complex, or combination is termed speciation. Each of the elemental im-purities has the potential to be present in differing oxidation or complexation states. However, arsenic and mercury are of par-ticular concern because of the differing toxicities of their inorganic and complexed organic forms.The arsenic limits are based on the inorganic (most toxic) form. Arsenic can be measured using a total-arsenic procedure under the assumption that all arsenic contained in the material under test is in the inorganic form. Where the limit is exceeded using a total-arsenic procedure, it may be possible to show via a procedure that quantifies the different forms that the inorgan-ic form meets the specification.The mercury limits are based upon the inorganic (2+) oxidation state. The methyl mercury form (most toxic) is rarely an issue for pharmaceuticals. Thus, the limit was established assuming the most common (mercuric) inorganic form. Limits for articles that have the potential to contain methyl mercury (e.g., materials derived from fish) are to be provided in the monograph.ROUTES OF EXPOSUREThe toxicity of an elemental impurity is related to its extent of exposure (bioavailability). The extent of exposure has been determined for each of the elemental impurities of interest for three routes of administration: oral, parenteral, and inhalational. These limits are based on chronic exposure. Consider the oral permissible daily exposures (PDEs) in Table 1, as a starting point in developing specific PDEs for other routes of administration except where otherwise stated in the individual monograph. [N OTE—The routes of administration of drug products are defined in Pharmaceutical Dosage Forms á1151ñ.]DRUG PRODUCTSThe limits described in the second through fourth columns of Table 1 are the base daily dose PDEs of the elemental impuri-ties of interest for a drug product taken by a patient according to indicated routes of administration.Parenteral ProductsParenteral drug products with maximum daily volumes up to 2 L may use the maximum daily volume to calculate permissi-ble concentrations from PDEs. For products whose daily volumes, as specified by labeling and/or established by clinical prac-tice, may exceed 2 L (e.g., saline, dextrose, TPNs, solutions for irrigation), a 2-L volume may be used to calculate permissible concentrations from PDEs.Table 1. Elemental Impurities for Drug ProductsElementOral DailyDose PDE a(m g/day)Parenteral DailyDose PDE(m g/day)Inhalational DailyDose PDE(m g/day)Cadmium522Lead555Inorganic arsenic a15152a See Speciation section.USP 39Chemical Tests / á232ñ Elemental Impurities—Limits 269Table 1. Elemental Impurities for Drug Products (Continued)Element Oral Daily Dose PDE a (m g/day)Parenteral Daily Dose PDE (m g/day)Inhalational DailyDose PDE(m g/day)Inorganic mercury a 3031Iridium 100101Osmium 100101Palladium 100101Platinum 100101Rhodium 100101Ruthenium 100101Chromium 1100011003Molybdenum 3000150010Nickel 200205Vanadium 100101Copper 300030030a See Speciationsection.Options for Demonstrating ComplianceDRUG PRODUCT ANALYSIS OPTIONThe results obtained from the analysis of a typical dosage unit, scaled to a maximum daily dose, are compared to the DailyDose PDE .Daily Dose PDE ³ measured value (m g/g) × maximum daily dose (g/day)The measured amount of each impurity is NMT the Daily Dose PDE , unless otherwise stated in the individual monograph.SUMMATION OPTIONSeparately add the amounts of each elemental impurity (in m g/g) present in each of the components of the drug product:Daily Dose PDE ³ [S M 1(C M × W M )] × D DM = each ingredient used to manufacture a dosage unitCM = element concentration in component (drug substance or excipient) (m g/g)W M = weight of component in a dosage unit (g/dosage unit)D D = number of units in the maximum daily dose (unit/day)The result of the summation of each impurity is NMT the Daily Dose PDE , unless otherwise stated in the individual mono-graph. Before products can be evaluated using this option, the manufacturer must ensure that additional elemental impurities cannot be inadvertently added through the manufacturing process or via the container closure system over the shelf life of the product.INDIVIDUAL COMPONENT OPTIONFor drug products with a daily dose of NMT 10g, if all drug substances and excipients in a formulation meet the concentra-tion limits shown in Table 2, then these components may be used in any proportion. No further calculation is necessary. While elemental impurities derived from the manufacturing process or the container closure system are not specifically provided for in the Individual Component Option , it is expected that the drug product manufacturer will ensure that these sources do not contribute significantly to the total content of elemental impurities.Change to read:DRUG SUBSTANCE AND EXCIPIENTSThe concentration of elemental impurities in drug substances and excipients must be controlled and, where present, docu-mented. The acceptable levels for these impurities depend on the material's ultimate use. Therefore, drug product manufactur-ers must determine the acceptable level of elemental impurities in the drug substances and excipients used to produce their products.270 á232ñ Elemental Impurities—Limits / Chemical Tests USP 39The values provided in Table 2 are example concentration limits for components (drug substances and excipients) of drug products dosed at a maximum daily dose of 10g/day. These values serve as default concentration limits to aid discussions be-tween drug product manufacturers and the suppliers of the components of their drug products. [N OTE—Individual compo-nents may need to be limited at levels different from those in the table depending on monograph-specific mitigating factors.]ANALYTICAL TESTINGIf, by process monitoring and supply-chain control, manufacturers can demonstrate compliance, then further testing may not be needed. When testing is done to demonstrate compliance, proceed as directed in Elemental Impurities—Proceduresá233ñ and minimally include arsenic, cadmium, lead, and mercury in the Target Elements evaluation.á233ñ ELEMENTAL IMPURITIES—PROCEDURESINTRODUCTIONThis chapter describes two analytical procedures (Procedures 1 and 2) for the evaluation of the levels of the elemental impuri-ties. The chapter also describes criteria for acceptable alternative procedures. By means of validation studies, analysts will con-firm that the analytical procedures described herein are suitable for use on specified material.Use of Alternative ProceduresThe chapter also describes criteria for acceptable alternative procedures. Alternative procedures that meet the validation re-quirements herein may be used in accordance with General Notices and Requirements 6.30, Alternative and Harmonized Methods and Procedures. Information on the Requirements for Alternate Procedure Validation is provided later in this chapter.SpeciationThe determination of the oxidation state, organic complex, or combination is termed speciation. Analytical procedures for speciation are not included in this chapter, but examples may be found elsewhere in USP–NF and in the literature.COMPENDIAL PROCEDURES 1 AND 2System standardization and suitability evaluation using applicable reference materials should be performed on the day of analysis.USP 39Chemical Tests / á233ñ Elemental Impurities—Procedures 271。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
231HEAVY METALSThis test is provided to demonstrate that the content of metallic impurities that are colored by sulfide ion, under the specified test conditions, does not exceed the Heavy metals limit specified in the individual monograph in percentage (by weight) of lead in the test substance, as determined by concomitant visual comparison (see Visual Comparison inthe section Procedure under Spectrophotometry and Light-Scattering 851) with a control prepared from a Standard Lead Solution. [ NOTE— Substances that typically will respond to this test are lead, mercury, bismuth, arsenic, antimony, tin, cadmium, silver, copper, and molybdenum. ]这个测试是规定在指定的测试条件下,硫离子与金属性杂质显色的范例,个论中测试物质中铅的质量含量与用铅标准溶液制备的控制物同时测试Determine the amount of heavy metals by Method I, unless otherwise specified in the individual monograph. Method I is used for substances that yield clear, colorless preparations under the specified test conditions. Method II is used for substances that do not yield clear, colorless preparations under the test conditions specified for Method I, or for substances that, by virtue of their complex nature, interfere with the precipitation of metals by sulfide ion, or for fixed and volatile oils. Method III, a wet-digestion method, is used only in those cases where neither Method I nor Method II can be used.Special ReagentsLead Nitrate Stock Solution— Dissolve 159.8 mg of lead nitrate in 100 mL of water to which has been added 1 mL of nitric acid, then dilute with water to 1000 mL. Prepare and store this solution in glass containers free from soluble lead salts.Standard Lead Solution— On the day of use, dilute 10.0 mL of Lead Nitrate Stock Solution with water to 100.0 mL. Each mL of Standard Lead Solution contains the equivalent of 10 µg of lead. A comparison solution prepared on the basis of 100 µL of Standard Lead Solution per g of substance being tested contains the equivalent of 1 part of lead per million parts of substance being tested.METHOD IpH 3.5 Acetate Buffer— Dissolve 25.0 g of ammonium acetate in 25 mL of water, and add 38.0 mL of 6 N hydrochloric acid. Adjust, if necessary, with 6 N ammonium hydroxide or 6 N hydrochloric acid to a pH of 3.5, dilute with water to 100 mL, and mix.Standard Preparation— Into a 50-mL color-comparison tube pipet 2 mL of Standard Lead Solution (20 µg of Pb), and dilute with water to 25 mL. Using a pH meter or short-range pH indicator paper as external indicator, adjust with 1 N acetic acid or 6 N ammonium hydroxide to a pH between 3.0 and 4.0, dilute with water to 40 mL, and mix.Test Preparation— Into a 50-mL color-comparison tube place 25 mL of the solution prepared for the test as directed in the individual monograph; or, using the designated volume of acid where specified in the individual monograph, dissolve in and dilute with water to 25 mL the quantity, in g, of the substance to be tested, as calculated by the formula:2.0/(1000L ),in which L is the Heavy metals limit, as a percentage. Using a pH meter or short-range pH indicator paper as external indicator, adjust with 1 N acetic acid or 6 N ammonium hydroxide to a pH between 3.0 and 4.0, dilute with water to 40 mL, and mix.Monitor Preparation— Into a third 50-mL color-comparison tube place 25 mL of a solution prepared as directed for Test Preparation, and add 2.0 mL of Standard Lead Solution. Using a pH meter or short-range pH indicator paper as external indicator, adjust with 1 N acetic acid or 6 N ammonium hydroxide to a pH between 3.0 and 4.0, dilute with water to 40 mL, and mix.Procedure— To each of the three tubes containing the Standard Preparation, the Test Preparation, and the Monitor Preparation, add 2 mL of pH 3.5 Acetate Buffer, then add 1.2 mL of thioacetamide–glycerin base TS, dilute with water to 50 mL, mix, allow to stand for 2 minutes, and view downward over a white surface *: the color of the solution from the Test Preparation is not darker than that of the solution from the Standard Preparation, and the color of the solution from the Monitor Preparation is equal to or darker than that of the solution from the Standard Preparation. [ NOTE— If the color of the Monitor Preparation islighter than that of the Standard Preparation, use Method II instead of Method I for the substance being tested. ]METHOD IINOTE— This method does not recover mercury.pH 3.5 Acetate Buffer— Prepare as directed under Method I.Standard Preparation— Pipet 4 mL of the Standard Lead Solution into a suitable test tube, and add 10 mL of 6 N hydrochloric acid.Test Preparation— Use a quantity, in g, of the substance to be tested as calculated by the formula:4.0/(1000L ),in which L is the Heavy metals limit, as a percentage. Transfer the weighed quantity of the substance to a suitable crucible, add sufficient sulfuric acid to wet the substance, and carefully ignite at a low temperature until thoroughly charred. (The crucible may be loosely covered with a suitable lid during the charring.) Add to the carbonized mass 2 mL of nitric acid and 5 drops of sulfuric acid, and heat cautiously until white fumes no longer are evolved. Ignite, preferably in a muffle furnace, at 500to 600, until the carbon is completely burned off (no longer than 2 hours). If carbon remains, allow the residue to cool, add a few drops of sulfuric acid, evaporate, and ignite again. Cool, add 5 mL of 6 N hydrochloric acid, cover, and digest on a steam bath for 10 minutes. Cool, and quantitatively transfer the solution to a test tube. Rinse the crucible with a second 5-mL portion of 6 N hydrochloric acid, and transfer the rinsing to the test tube.Monitor Preparation— Pipet 4 mL of the Standard Lead Solution into a crucible identical to that used for the Test Preparation and containing a quantity of the substance under test that is equal to 10% of the amount required for the Test Preparation. Evaporate on a steam bath to dryness. Ignite at the same time, in the same muffle furnace, and under the same conditions used for the Test Preparation. Cool, add 5 mL of 6 N hydrochloric acid, cover, and digest on a steam bath for 10 minutes. Cool, and quantitatively transfer to atest tube. Rinse the crucible with a second 5-mL portion of 6 N hydrochloric acid, and transfer the rinsing to the test tube.Procedure— Adjust the solution in each of the tubes containing the Standard Preparation, the Test Preparation, and the Monitor Preparation with ammonium hydroxide, added cautiously and dropwise, to a pH of 9. Cool, and adjust with glacial acetic acid, added dropwise, to a pH of 8, then add 0.5 mL in excess. Using a pH meter or short-range pH indicator paper as external indicator, check the pH, and adjust, if necessary, with 1 N acetic acid or 6 N ammonium hydroxide to a pH between 3.0 and 4.0. Filter, if necessary, washing the filter with a few mL of water, into a 50-mL color-comparison tube, and then dilute with water to 40 mL. Add 2 mL of pH 3.5 Acetate Buffer, then add 1.2 mL of thioacetamide–glycerin base TS, dilute with water to 50 mL, mix, allow to stand for 2 minutes, and view downward over a white surface*: the color of the solution from the Test Preparation is not darker than that of the solution from the Standard Preparation, and the color of the solution from the Monitor Preparation is equal to or darker than that of the solution from the Standard Preparation. [ NOTE— If the color of the solution from the Monitor Preparation is lighter than that of the solution from the Standard Preparation, proceed as directed for Method III for the substance being tested. ]METHOD IIIpH 3.5 Acetate Buffer— Prepare as directed under Method I.Standard Preparation— Transfer a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid to a clean, dry, 100-mL Kjeldahl flask, and add a further volume of nitric acid equal to the incremental volume of nitric acid added to the Test Preparation. Heat the solution to the production of dense, white fumes; cool; cautiously add 10 mL of water; and, if hydrogen peroxide was used in treating the Test Preparation, add a volume of 30 percent hydrogen peroxide equal to that used for the substance being tested. Boil gently to the production of dense, white fumes. Again cool, cautiously add 5 mL of water, mix, and boil gently to the production of dense, white fumes and to a volume of 2 to 3 mL. Cool, dilute cautiously with a few mL of water, add 2.0 mL of Standard Lead Solution (20 µg of Pb), and mix. Transferto a 50-mL color-comparison tube, rinse the flask with water, adding the rinsing to the tube until the volume is 25 mL, and mix.Test Preparation— Unless otherwise indicated in the individual monograph, use a quantity, in g, of the substance to be tested as calculated by the formula:2.0/(1000L ),in which L is the Heavy metals limit, as a percentage.If the substance is a solid—Transfer the weighed quantity of the test substance to a clean, dry, 100-mL Kjeldahl flask. [ NOTE— A 300-mL flask may be used if the reaction foams excessively. ] Clamp the flask at an angle of 45, and add a sufficient quantity of a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid to moisten the substance thoroughly. Warm gently until the reaction commences, allow the reaction to subside, and add portions of the same acid mixture, heating after each addition, until a total of 18 mL of the acid mixture has been added. Increase the amount of heat, and boil gently until the solution darkens. Cool, add 2 mL of nitric acid, and heat again until the solution darkens. Continue the heating, followed by addition of nitric acid until no further darkening occurs, then heat strongly to the production of dense, white fumes. Cool, cautiously add 5 mL of water, boil gently to the production of dense, white fumes, and continue heating until the volume is reduced to a few mL. Cool, cautiously add 5 mL of water, and examine the color of the solution. If the color is yellow, cautiously add 1 mL of 30 percent hydrogen peroxide, and again evaporate to the production of dense, white fumes and a volume of 2 to 3 mL. If the solution is still yellow, repeat the addition of 5 mL of water and the peroxide treatment. Cool, dilute cautiously with a few mL of water, and rinse into a 50-mL color-comparison tube, taking care that the combined volume does not exceed 25 mL.If the substance is a liquid—Transfer the weighed quantity of the test substance to a clean, dry, 100-mL Kjeldahl flask. [ NOTE— A 300-mL flask may be used if the reaction foams excessively. ] Clamp the flask at an angle of 45, and cautiously add a few mL of a mixture of 8 mL of sulfuric acid and 10 mL of nitric acid. Warm gently until the reaction commences, allow the reaction to subside, and proceed as directed for If the substance is a solid, beginning with ―add portions of the same acid mixture.‖Monitor Preparation— Proceed with the digestion, using the same amount of sample and the same procedure as directed in the subsection If the substance is a solid in the section Test Preparation, until the step ―Cool, dilute cautiously with a few mL of water.‖ Add 2.0 mL of Lead Standard Solution (20 µg of lead), and mix. Transfer to a 50-mL color comparison tube, rinse the flask with water, adding the rinsing to the tube until the volume is 25 mL, and mix.Procedure— Treat the Test Preparation, the Standard Preparation, and the Monitor Preparation as follows. Using a pH meter or short-range pH indicator paper as external indicator, adjust the solution to a pH between 3.0 and 4.0 with ammonium hydroxide (a dilute ammonia solution may be used, if desired, as the specified range is approached), dilute with water to 40 mL, and mix.To each tube add 2 mL of pH 3.5 Acetate Buffer, then add 1.2 mL ofthioacetamide–glycerin base TS, dilute with water to 50 mL, mix, allow to stand for 2 minutes, and view downward over a white surface*: the color of the Test Preparation is not darker than that of the Standard Preparation, and the color of the Monitor Preparation is equal to or darker than that of the Standard Preparation.*In those countries or jurisdictions where thioacetamide cannot be used, add 10 mL of freshly prepared hydrogen sulfide TS to each of the tubes, mix, allow to stand for 5 minutes, and view downward over a white surface.Auxiliary Information—Staff Liaison : Kahkashan Zaidi, Ph.D., Senior Scientific Associate Expert Committee : (GC05) General Chapters 05USP29–NF24 Page 2556Pharmacopeial Forum : Volume No. 31(5) Page 1435Phone Number : 1-301-816-8269。